Literature DB >> 12768435

Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.

Eun-Kyeong Jo1, Yue Wang2, Hirokazu Kanegane3, Takeshi Futatani2, Chang-Hwa Song1, Jeong-Kyu Park1, Jung Soo Kim4, Dong Soo Kim5, Kang-Mo Ahn6, Sang-Il Lee6, Hyeon Jin Park7, Youn Soo Hahn7, Jae-Ho Lee8, Toshio Miyawaki2.   

Abstract

Mutations in the Bruton's tyrosine kinase ( BTK) gene are responsible for X-linked agammaglobulinemia (XLA). We identified BTK mutations in six patients with presumed XLA from unrelated Korean families. Four out of six mutations were novel: two missense mutations (P565T, C154Y), a point mutation in a splicing donor site (IVS11+1G>A), and a large deletion (a 6.1-kb deletion including BTK exons 11-18). The large deletion, identified by long-distance PCR, revealed Alu-Alu mediated recombination extended from an Alu sequence in intron 10 to another Alu sequence in intron 18, spanning a distance of 6.1 kb. The two known mutations consisted of one missense (G462D) mutation, and a point mutation in a splicing acceptor site (IVS7-9A>G). This study suggests that large genomic rearrangements involving Alu repeats are few but an important component of the spectrum of BTK mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768435     DOI: 10.1007/s10038-003-0032-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.

Authors:  S Hashimoto; S Tsukada; M Matsushita; T Miyawaki; Y Niida; A Yachie; S Kobayashi; T Iwata; H Hayakawa; H Matsuoka; I Tsuge; T Yamadori; T Kunikata; S Arai; K Yoshizaki; N Taniguchi; T Kishimoto
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

Review 2.  Molecular approaches to analysis of X-linked immunodeficiencies.

Authors:  M E Conley
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions.

Authors:  J Rohrer; Y Minegishi; D Richter; J Eguiguren; M E Conley
Journal:  Clin Immunol       Date:  1999-01       Impact factor: 3.969

4.  Expression of the gene defect in X-linked agammaglobulinemia.

Authors:  M E Conley; P Brown; A R Pickard; R H Buckley; D S Miller; W H Raskind; J W Singer; P J Fialkow
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

5.  A novel mutation (Cys145-->Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male.

Authors:  S J Kornfeld; R N Haire; S J Strong; H Tang; S S Sung; S M Fu; G W Litman
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

Review 6.  Alu repeats and human disease.

Authors:  P L Deininger; M A Batzer
Journal:  Mol Genet Metab       Date:  1999-07       Impact factor: 4.797

7.  Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.

Authors:  T Futatani; T Miyawaki; S Tsukada; S Hashimoto; T Kunikata; S Arai; M Kurimoto; Y Niida; H Matsuoka; Y Sakiyama; T Iwata; S Tsuchiya; O Tatsuzawa; K Yoshizaki; T Kishimoto
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

8.  A case of X-linked agammaglobulinemia diagnosed in adulthood.

Authors:  D M Stewart; L Tian; D L Nelson
Journal:  Clin Immunol       Date:  2001-04       Impact factor: 3.969

9.  DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.

Authors:  I Vorechovský; M Vihinen; G de Saint Basile; S Honsová; L Hammarström; S Müller; L Nilsson; A Fischer; C I Smith
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

10.  Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.

Authors:  P Sideras; S Müller; H Shiels; H Jin; W N Khan; L Nilsson; E Parkinson; J D Thomas; L Brandén; I Larsson
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

View more
  6 in total

1.  Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.

Authors:  Menno C van Zelm; Corinne Geertsema; Nicole Nieuwenhuis; Dick de Ridder; Mary Ellen Conley; Claudine Schiff; Ilhan Tezcan; Ewa Bernatowska; Nico G Hartwig; Elisabeth A M Sanders; Jiri Litzman; Irina Kondratenko; Jacques J M van Dongen; Mirjam van der Burg
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

2.  Correlations between long inverted repeat (LIR) features, deletion size and distance from breakpoint in human gross gene deletions.

Authors:  Nevim Aygun
Journal:  Sci Rep       Date:  2015-02-06       Impact factor: 4.379

3.  Multi-pathway DNA-repair reporters reveal competition between end-joining, single-strand annealing and homologous recombination at Cas9-induced DNA double-strand breaks.

Authors:  Bert van de Kooij; Alex Kruswick; Haico van Attikum; Michael B Yaffe
Journal:  Nat Commun       Date:  2022-09-08       Impact factor: 17.694

4.  The contribution of alu elements to mutagenic DNA double-strand break repair.

Authors:  Maria E Morales; Travis B White; Vincent A Streva; Cecily B DeFreece; Dale J Hedges; Prescott L Deininger
Journal:  PLoS Genet       Date:  2015-03-11       Impact factor: 5.917

Review 5.  Alu mobile elements: from junk DNA to genomic gems.

Authors:  Sami Dridi
Journal:  Scientifica (Cairo)       Date:  2012-12-16

6.  Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.

Authors:  Yu-Hsin Yeh; Meng-Ying Hsieh; Wen-I Lee; Jing-Long Huang; Li-Chen Chen; Kuo-Wei Yeh; Liang-Shiou Ou; Tsung-Chieh Yao; Chao-Yi Wu; Syh-Jae Lin
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.